Journal profile · Hematology
Vox Sanguinis
ISSN 0042-9007 · eISSN 1423-0410 · Wiley-Blackwell Publishing Ltd · ENGLAND · Bimonthly · Founded 1953
Vox Sanguinis: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.53; hybrid open access; APC about USD 4,150; median 96 days to acceptance (105 articles, last 24 months); community-reported acceptance: fairly easy; 214 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Vox Sanguinis is published by Wiley-Blackwell Publishing Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Blood groups and transfusion, Blood transfusion and management and Erythrocyte Function and Pathophysiology, together about 39.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Vox Sanguinis is an international journal published on behalf of the International Society of Blood Transfusion (ISBT), reporting on significant developments and advancements in transfusion medicine.Aims and ScopeVox Sanguinis reports on all issues related to transfusion medicine, ‘vein to vein’ from donor to recipient, and including cellular therapies. Comments, reviews, original articles, short reports and international fora are published, grouped into eight main sections: 1) Donors and Donations Donor recruitment and retention Donor selection Donor health (vigilance, side effects of donation) Big data analysis and blood donation 2) Blood Component Collection and Production Blood collection methods and devices (including apheresis) Blood component preparation and storage Inventory management Collection and storage of cells for cell therapies Quality management and good manufacturing practice Automation and information technology Plasma fractionation techniques and plasma derivatives 3) Transfusion-transmitted Disease and its Prevention Identification and epidemiology of infectious pathogens transmissible by blood Donor testing for transfusion-transmissible infectious pathogens Bacterial contamination of blood components Pathogen inactivation 4) Transfusion Medicine and New Therapies Transfusion practice, thresholds and audits Transfusion efficacy assessment, clinical trials Non-infectious transfusion adverse events Therapeutic apheresis 5) Haemovigilance Near misses, adverse events and side effects throughout the transfusion chain Monitoring, reporting and analysis of those adverse events and side effects Activities aiming at increasing the safety of the whole transfusion chain Standardization of the definition of adverse events and side effects 6) Patient Blood Management Caring for patients who might need a transfusion Transfusion indication decision-making process Search for the optimal patient outcomes Study of transfusion alternatives Autologous blood transfusion 7) Immunohaematology Red cell, platelet and granulocyte immunohaematology Blood phenotyping and genotyping Molecular genetics of blood groups Alloimmunity of blood Pre-transfusion testing Autoimmunity in transfusion medicine Blood typing reagents and technology Immunogenetics of blood cells and serum proteins: polymorphisms and function Complement in immunohaematology Parentage testing and forensic immunohaematology 8) Cellular Therapies Cellular therapy (sources; products; processing and s
From the journal's Aims & Scope
Research area (LetPub): Hematology
Editor-in-chief Miquel LozanoPublisher website
Editorial board by country: none in mainland China; most named United States 2, Japan 1, France 1, Spain 1, Canada 1 (11 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Blood groups and transfusionMedicine20.8%
- Blood transfusion and managementMedicine10.1%
- Erythrocyte Function and PathophysiologyMedicine8.7%
- Blood donation and transfusion practicesBusiness, Management and Accounting8.2%
- Platelet Disorders and TreatmentsMedicine5.7%
- Hepatitis B Virus StudiesMedicine4.5%
- Hemoglobinopathies and Related DisordersMedicine3.9%
- Blood disorders and treatmentsBiochemistry, Genetics and Molecular Biology3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: EBSCO, ProQuest, AGRICOLA
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.53LetPub ·
- Impact factor (publisher) 2025
- 1.6Publisher website ·
- CiteScore 2026-06
- 3.2LetPub ·
- CiteScore (publisher) 2025
- 3.2Publisher website ·
- SJR 2026-06
- 0.59LetPub ·
- SNIP 2026-06
- 1.04LetPub ·
- h-index
- 77LetPub ·
- h-index
- 130OpenAlex ·
- i10-index
- 4,752OpenAlex ·
- 2-year mean citedness
- 1.54OpenAlex ·
- Self-citation rate
- 18.8%LetPub ·
- Share of gold OA articles
- 40.47%LetPub ·
Volume
- Articles per year
- 147LetPub ·
- Articles per year (publisher) 2025
- 168Publisher website ·
- Downloads per year (publisher) 2025
- 446,637Publisher website ·
Articles by year OpenAlex count · 16,595 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 223 | 154 | 74 |
| 2025 | 214 | 120 | 311 |
| 2024 | 209 | 138 | 611 |
| 2023 | 197 | 127 | 714 |
| 2022 | 175 | 55 | 968 |
| 2021 | 194 | 80 | 1,580 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
96 daysMedian, submission to acceptance · P25–P75 62 days – 141 days
- Acceptance to online
- median 18 days (105 articles)
- Submission to online
- median 115 days
- Sample
- 105 articles with submission and acceptance dates (425 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher) 2025
- 40%Publisher website ·
- Submission to first decision 2025
- 26 daysPublisher website ·
- Submission to acceptance 2025
- 92 daysPublisher website ·
- Acceptance to publication 2025
- 22 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,150 / EUR 3,470 / GBP 2,780 | — | — | |
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 3–6
- Manuscript length
- ≤ 5,000 words
- Reference style
- Numbered, in order of citation
- First submission
- Free format: the journal's layout is not required
- Highlights
- Required
- Cover letter
- Required
Article types accepted13, with length limits
- case reportOriginal ArticlesOriginal Articles are judged on their novelty and importance to the respective field. Original Articles should not exceed 5,000 words (includin…Length not stated
- case reportsThe submission of Case Reports is not encouraged.Length not stated
- commentaryOriginal ArticlesOriginal Articles are judged on their novelty and importance to the respective field. Original Articles should not exceed 5,000 words (includin…Length not stated
- international forumPeriodically, Vox Sanguinis publishes an International Forum (IF) to examine the management of a topic in different jurisdictions.Length not stated
- letterOriginal ArticlesOriginal Articles are judged on their novelty and importance to the respective field. Original Articles should not exceed 5,000 words (includin…Length not stated
- letters to the editorLetters to the Editor are welcome but should contain no more than 800 words and a maximum of 10 references.Length not stated
- obituariesObituaries should not exceed 600 words (excluding authors names and affiliations) and should be accompanied by a headshot of the person, with the aim being to p…Length not stated
- original articleOriginal ArticlesOriginal Articles are judged on their novelty and importance to the respective field. Original Articles should not exceed 5,000 words (includin…main text ≤ 5,000 words
- original articlesOriginal Articles are judged on their novelty and importance to the respective field. Original Articles should not exceed 5,000 words (including the title page,…Length not stated
- reportsReports should be a maximum of approximately 6,600 words and should include an abstract (200 words), which need not be structured.Length not stated
- reviewOriginal ArticlesOriginal Articles are judged on their novelty and importance to the respective field. Original Articles should not exceed 5,000 words (includin…Length not stated
- reviewsReview articles are published on subjects of interest to the broad readership of the journal. Articles should not exceed 6,600 words (including the title page, …Length not stated
- short reportShort reports should be a maximum of 2,500 words including the abstract, main text, references, figure legends and tables, but excluding the author names and af…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Peer review, Plagiarism, Self-archiving
- AI use Artificial Intelligence Generated Content
Artificial Intelligence Generated Content (AIGC) tools — such as ChatGPT and others based on large language models (LLMs) — cannot be considered capable of initiating an original piece of research without direction by human authors. They also cannot be accountable for a published work or for a research design, which is a generally held requirement of authorship, nor do they have legal standing or …
Source ↗Publisher website ·- Authorship Authorship
On initial submission, the submitting author will be prompted to provide the email address and country for all contributing authors.
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest Statement
Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the section "Conflict of Interest" in the Editorial Policies and Ethical Considerations' section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.
Source ↗Publisher website ·- Data availability Data Sharing and Data Accessibility
The journal encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper.
Source ↗Publisher website ·- Publication ethics 5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS
Peer Review and Acceptance The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Except where otherwise stated, manuscripts are single-blind peer reviewed. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements. The journal operates a st…
Source ↗Publisher website ·- License & copyright
Standard copyright or open access under Creative Commons License. Model summary
Authors may choose to publish under the terms of the journal’s standard copyright agreement, or open access under the terms of a Creative Commons License.
Source ↗Publisher website ·- Peer review Peer Review and Acceptance
Single-blind peer review. Model summary
The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Except where otherwise stated, manuscripts are single-blind peer reviewed. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements.
Source ↗Publisher website ·- Plagiarism
Uses iThenticate CrossCheck for plagiarism detection. Model summary
Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts.
Source ↗Publisher website ·- Self-archiving
Self-archiving allowed under specific conditions. Model summary
Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1953
- ISSN
- 0042-9007
- Electronic ISSN
- 1423-0410
- Society / sponsor
- International Society of Blood Transfusion
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about Vox Sanguinis
What CAS zone is Vox Sanguinis in?
In the 2025 upgraded edition of the CAS Journal Ranking, Vox Sanguinis is in Zone 4 of Medicine, and in Zone 4 of the minor category Hematology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Vox Sanguinis?
The latest impact factor listed by LetPub is 1.53; CiteScore 3.2, h-index 130.
How long does peer review take at Vox Sanguinis?
Based on the dates recorded on 105 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 96 days (interquartile range 62–141 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 40% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Vox Sanguinis?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 3–6; Manuscript length: ≤ 5,000 words; Reference style: Numbered, in order of citation; First submission: Free format: the journal's layout is not required; Highlights: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Vox Sanguinis based?
Of the 11 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (2), Japan (1) and France (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Vox Sanguinis?
According to LetPub and DOAJ records, Vox Sanguinis is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Vox Sanguinis open access, and what is the APC?
Vox Sanguinis is a hybrid journal. For open-access publication: APC about USD 4,150.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .